Defining Endpoints and Biomarkers in Inflammatory Bowel Disease: Moving the Needle Through Clinical Trial Design

Abreu, M. T., Sandborn, W. J., Cataldi, F., D’Haens, G., Feagan, B. G., Hanauer, S., … Tomaino, J. (2020). Defining Endpoints and Biomarkers in Inflammatory Bowel Disease: Moving the Needle Through Clinical Trial Design. Gastroenterology, 159(6), 2013-2018.e7. https://doi.org/10.1053/j.gastro.2020.07.064